Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
Jenny Chang‐Claude(Universität Hamburg), Volker Arndt(German Cancer Research Center), Angela Cox, Marjanka K. Schmidt(University of Cambridge), Mark S. Goldberg(Friends United), Hiltrud Brauch(German Cancer Research Center), Peter A. Fasching(Universitätsklinikum Erlangen), Graham G. Giles(The University of Melbourne), Jose E. Castelao(Servicio Gallego de Salud), Simon S. Cross(University of Sheffield), Manuela Gago-Domínguez(University of Southern California), Susan M. Gapstur(Centre international de recherche sur le cancer), Lynn Jongen(KU Leuven), Jonine D. Figueroa, Thérèse Truong(Université Paris-Sud), Annegien Broeks, Anthony J. Swerdlow(Institute of Cancer Research), Joe Dennis(University of Cambridge), Rudolf Kaaks(German Cancer Research Center), Pascal Guénel(Inserm), Alison M. Dunning(University of Cambridge), Kamila Czene(Karolinska Institutet), Roger L. Milne(The University of Melbourne), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Douglas F. Easton(University of Cambridge), Sabine Behrens(German Cancer Research Center), Per Hall(Karolinska Institutet), Jacques Simard(Université Laval), Dieter Flesch‐Janys, Stig E. Bojesen(University of Copenhagen), Montserrat García‐Closas(Institute of Cancer Research), Mia M. Gaudet(Cancer Prevention Institute of California), Hermann Brenner(Universidad de Granada), Anja Rudolph(Institut für Qualität im Management (Germany)), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Kathrin Thoene(Universität Hamburg), Melissa C. Southey(The University of Melbourne), Qin Wang(University of Cambridge), Ute Hamann(German Cancer Research Center), Matthias W. Beckmann, John L. Hopper(The University of Melbourne), Fergus J. Couch(Mayo Clinic), Ursula Eilber(University of Helsinki), Minouk J. Schoemaker(Institute of Cancer Research), Manjeet K. Bolla(University of Cambridge)
Cited by 26
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k